About Boehringer Ingelheim
Boehringer Ingelheim is a company founded in 1885.. Boehringer Ingelheim has completed 16 acquisitions, including AMAL Therapeutics, AbeXXa Biologics and Actimis.
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$268.81 K (USD), Grant
Sep 01, 2022
- Investors
-
Employee Count
Employee Count
-
Investments & Acquisitions
AMAL Therapeutics
& 15 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Software Development Team
63 people
Leadership Team
54 people
Finance and Accounting
26 people
Sales and Marketing
18 people
Head Team
17 people
Senior Team
12 people
Product Management Team
11 people
Creative and Marketing Team
6 people
Unlock access to complete
Funding Insights of Boehringer Ingelheim
- Total Funding Total Funding
- Total Rounds 11
- Last Round Grant — $268,807
-
First Round
First Round
(01 Jan 2016)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2022 | Amount | Grant - Boehringer Ingelheim | Valuation |
investors |
|
| Jul, 2022 | Amount | Grant - Boehringer Ingelheim | Valuation |
investors |
|
| Mar, 2021 | Amount | Grant - Boehringer Ingelheim | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Boehringer Ingelheim
Boehringer Ingelheim has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Boehringer Ingelheim
Boehringer Ingelheim has strategically engaged in corporate development activities, having acquired 16 companies. Notable acquisitions include AMAL Therapeutics, AbeXXa Biologics and Actimis. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Technology for immunotherapy drug discovery is developed via high-throughput screening.
|
2019 | ||||
|
Provider of veterinary healthcare products development & marketing services
|
2017 | ||||
|
Cytokines for cancer treatment are developed with tumor-site activation.
|
2017 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Boehringer Ingelheim
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Boehringer Ingelheim Comparisons
Competitors of Boehringer Ingelheim
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Boehringer Ingelheim
Frequently Asked Questions about Boehringer Ingelheim
When was Boehringer Ingelheim founded?
Boehringer Ingelheim was founded in 1885 and raised its 1st funding round 131 years after it was founded.
Who is the current CEO of Boehringer Ingelheim?
Jean-Michel Boers is the current CEO of Boehringer Ingelheim.
What does Boehringer Ingelheim do?
Boehringer Ingelheim was founded in 1885 as a pharmaceutical entity focused on generic drugs and clinical research services. Operations are centered in the healthcare sector, with emphasis on drug development and research support. Leadership includes Co-CEO Jean-Michel Boers, CEO Hubertus Von Baumbach, and Managing Director Fei Shen. The company maintains a presence through its domain boehringer-ingelheim.com, though specific location details are not specified.
How many acquisitions has Boehringer Ingelheim made?
Boehringer Ingelheim has made 16 acquisitions, including AMAL Therapeutics, AbeXXa Biologics, and Actimis.
Who are Boehringer Ingelheim's investors?
Boehringer Ingelheim has 1 investor. Key investors include European Union.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.